Effect of Prebiotic Intake on Adiposity, Satiety and Gut Microbiota in Overweight and Obese Children
1 other identifier
interventional
42
1 country
1
Brief Summary
Currently, over one third of Canadian children and youth aged five to seventeen are overweight or obese. Childhood obesity leads to increased risks of co-morbidities such as type 2 diabetes, fatty liver disease, cardiovascular disease and certain types of cancers. Changes in the food supply have been linked to obesity and include a decrease in the intake of dietary fiber. Prebiotic fibers are a group of non-digestible carbohydrates that modulate the composition and actions of the gut microbiota and have been shown to reduce body fat and energy intake in overweight and obese adults. The investigators hypothesis is that prebiotic fiber intake in overweight and obese children will similarly result in improvements in body composition and reduced energy intake.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2014
CompletedFirst Submitted
Initial submission to the registry
April 25, 2014
CompletedFirst Posted
Study publicly available on registry
April 29, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2017
CompletedOctober 26, 2017
October 1, 2017
10 months
April 25, 2014
October 24, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Body fat
Change in baseline fat mass at 16 weeks. Measured by dual energy x-ray absorptiometry.
16 weeks
Secondary Outcomes (1)
Appetite regulation
16 weeks
Other Outcomes (4)
Gut microbiota
16 weeks
Serum lipids
16 weeks
Serum glucose and insulin
16 weeks
- +1 more other outcomes
Study Arms (2)
Prebiotic fiber
EXPERIMENTALThe intervention group will consume an 8 gram dose of prebiotic fiber one time per day approximately 30 minutes prior to their evening meal.
Placebo
PLACEBO COMPARATORThe placebo group will consume an isocaloric dose of placebo (maltodextrin; 3.3 grams) one time per day approximately 30 minutes prior to their evening meal.
Interventions
Dissolved in water.
Eligibility Criteria
You may qualify if:
- Boys and girls between the ages of 7-12 years old
- BMI percentiles \>85th percentile for their age and sex
- Tanner stage of ≤ 3, girls premenarche
You may not qualify if:
- Tanner stage of \>3 or girls postmenarchal
- Use of antibiotics up to 3 months prior to study
- Regular prebiotic supplement and/or probiotic supplement use
- Subjects unable to provide consent (parental) or assent (child)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Calgarylead
- Alberta Children's Hospitalcollaborator
Study Sites (1)
University of Calgary
Calgary, Alberta, T2N 1N4, Canada
Related Publications (2)
Nicolucci AC, Hume MP, Martinez I, Mayengbam S, Walter J, Reimer RA. Prebiotics Reduce Body Fat and Alter Intestinal Microbiota in Children Who Are Overweight or With Obesity. Gastroenterology. 2017 Sep;153(3):711-722. doi: 10.1053/j.gastro.2017.05.055. Epub 2017 Jun 5.
PMID: 28596023RESULTHume MP, Nicolucci AC, Reimer RA. Prebiotic supplementation improves appetite control in children with overweight and obesity: a randomized controlled trial. Am J Clin Nutr. 2017 Apr;105(4):790-799. doi: 10.3945/ajcn.116.140947. Epub 2017 Feb 22.
PMID: 28228425RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Raylene A Reimer, PhD, RD
University of Calgary
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 25, 2014
First Posted
April 29, 2014
Study Start
February 1, 2014
Primary Completion
December 1, 2014
Study Completion
September 1, 2017
Last Updated
October 26, 2017
Record last verified: 2017-10